Guidance
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) - update 15 March 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
This document has been updated: Version 30 July 2021.
Authors
Languages
- English
Publication year
2021
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- COVID-19
Countries
- Chad
Organisations
- World Health Organization (WHO)
